U.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19
Oral medications patients take when symptoms first appear are being tested, but initial results are not expected for several months
TB Outbreak May Be Linked to Bone Repair Product
Aziyo Biologics recalling 154 containers of the bone putty that includes human cells and is used in a range of orthopedic procedures
European Union Opens Doors to American Travelers
Decision is nonbinding and each EU nation can decide how to regulate visitors
Rare Events of ITP Associated With ChAdOx1 Vaccine
Small increased risk for idiopathic thrombocytopenic purpura seen after first dose with estimated incidence of 1.13 cases per 100,000 doses
Obesity Tied to Long-Term COVID-19 Complications
Increases seen for hospital admission, mortality, need for diagnostic medical tests occurring 30+ days after positive COVID-19 test
16.3 Percent of Pregnant Women Have Had COVID-19 Vaccine
Receipt of vaccine highest for women aged 35 to 49 years and for Asian and White versus Hispanic and Black women
U.S. Supreme Court Strikes Down Challenge to Affordable Care Act
Ruling did not address whether the Obama-era law can continue without a provision that requires Americans obtain insurance or pay a penalty
Ahead of Tokyo Olympics, Japan Eases COVID-19 Restrictions
Experts say it is crucial to accelerate the vaccine rollout for the Olympics to be safe
CureVac’s COVID-19 Vaccine Only 47 Percent Effective
Vaccine's efficacy is the lowest reported so far by a COVID-19 vaccine maker
U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster Shots
It is not clear yet whether, or when, booster shots might be necessary
